AngioDynamics, Inc.
ANGO
$10.86
$1.2012.42%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -13.06% | -12.85% | -10.28% | -3.19% | 0.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.06% | -12.85% | -10.28% | -3.19% | 0.49% |
| Cost of Revenue | -16.54% | -13.75% | -9.29% | 2.51% | 4.40% |
| Gross Profit | -9.68% | -12.00% | -11.22% | -8.43% | -3.04% |
| SG&A Expenses | -0.05% | -2.36% | -0.19% | -0.15% | 2.24% |
| Depreciation & Amortization | -32.69% | -31.77% | -30.56% | -22.65% | -15.78% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.56% | -7.14% | -3.89% | 0.63% | 2.30% |
| Operating Income | -52.65% | -84.62% | -112.02% | -63.16% | -35.55% |
| Income Before Tax | -2,456.47% | -4,081.92% | -252.04% | -407.37% | 73.76% |
| Income Tax Expenses | -362.38% | 131.79% | -265.36% | -240.89% | 280.76% |
| Earnings from Continuing Operations | -1,491.96% | -3,870.26% | -251.53% | -416.55% | 56.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,491.96% | -3,870.26% | -251.53% | -416.55% | 56.85% |
| EBIT | -52.65% | -84.62% | -112.02% | -63.16% | -35.55% |
| EBITDA | -348.68% | -246.38% | -217.21% | -146.67% | -64.03% |
| EPS Basic | -1,480.95% | -4,004.14% | -244.11% | -405.20% | 57.64% |
| Normalized Basic EPS | -37.46% | -53.71% | -73.71% | -44.84% | -25.56% |
| EPS Diluted | -1,476.04% | -4,050.13% | -244.82% | -405.73% | 57.61% |
| Normalized Diluted EPS | -37.63% | -53.92% | -73.56% | -44.70% | -25.41% |
| Average Basic Shares Outstanding | 1.92% | 1.95% | 1.78% | 1.55% | 1.36% |
| Average Diluted Shares Outstanding | 1.84% | 1.87% | 1.86% | 1.63% | 1.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
